NVS vs. NVO
Compare and contrast key facts about Novartis AG (NVS) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NVS or NVO.
Correlation
The correlation between NVS and NVO is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NVS vs. NVO - Performance Comparison
Key characteristics
NVS:
0.66
NVO:
-0.82
NVS:
1.02
NVO:
-1.02
NVS:
1.13
NVO:
0.86
NVS:
0.57
NVO:
-0.66
NVS:
1.28
NVO:
-1.45
NVS:
8.94%
NVO:
21.15%
NVS:
17.23%
NVO:
37.71%
NVS:
-41.72%
NVO:
-71.32%
NVS:
-11.56%
NVO:
-43.02%
Fundamentals
NVS:
$211.16B
NVO:
$366.23B
NVS:
$5.87
NVO:
$3.18
NVS:
18.21
NVO:
26.23
NVS:
3.19
NVO:
1.20
NVS:
$51.07B
NVO:
$290.40B
NVS:
$38.17B
NVO:
$245.88B
NVS:
$20.75B
NVO:
$148.56B
Returns By Period
In the year-to-date period, NVS achieves a 9.87% return, which is significantly higher than NVO's -3.05% return. Over the past 10 years, NVS has underperformed NVO with an annualized return of 6.27%, while NVO has yielded a comparatively higher 15.70% annualized return.
NVS
9.87%
9.62%
-9.10%
8.06%
7.50%
6.27%
NVO
-3.05%
5.99%
-38.20%
-30.58%
23.23%
15.70%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NVS vs. NVO — Risk-Adjusted Performance Rank
NVS
NVO
NVS vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NVS vs. NVO - Dividend Comparison
NVS's dividend yield for the trailing twelve months is around 3.53%, more than NVO's 1.73% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVS Novartis AG | 3.53% | 3.88% | 3.44% | 3.91% | 4.08% | 3.40% | 2.87% | 3.72% | 3.50% | 4.06% | 3.51% | 3.14% |
NVO Novo Nordisk A/S | 1.73% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
NVS vs. NVO - Drawdown Comparison
The maximum NVS drawdown since its inception was -41.72%, smaller than the maximum NVO drawdown of -71.32%. Use the drawdown chart below to compare losses from any high point for NVS and NVO. For additional features, visit the drawdowns tool.
Volatility
NVS vs. NVO - Volatility Comparison
The current volatility for Novartis AG (NVS) is 7.73%, while Novo Nordisk A/S (NVO) has a volatility of 13.38%. This indicates that NVS experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NVS vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Novartis AG and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities